[Intravenous streptokinase versus heparin in the acute phase of myocardial infarction. Randomized prospective study in southeast France].
D000368:Aged; D000792:Angiography; D004562:Electrocardiography; D005260:Female; D005340:Fibrinogen / Q000032:analysis; D005602:France; D006352:Heart Ventricles / Q000503:physiopathology; D006493:Heparin / Q000627:therapeutic use*; D006801:Humans; D007262:Infusions, Intravenous; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000188:drug therapy* / Q000401:mortality; D011446:Prospective Studies; D011897:Random Allocation; D013300:Streptokinase / Q000008:administration & dosage / Q000627:therapeutic use*
D005340:Fibrinogen; D006493:Heparin; D013300:Streptokinase
Streptokinase intraveineuse versus héparine à la phase aiguë de l'infarctus du myocarde. Etude prospective randomisée France Sud-Est.